• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-29

  Park, Lee, and Kim challenge the canonical view that AMPK uniformly activates autophagy during glucose deprivation. Their evidence shows that AMPK can restrain ULK1 initiation signaling during acute energy stress while preserving the autophagy machinery for recovery, redefining how energy sensing and autophagy should be interpreted in cell-based studies.

• Cycloastragenol Protects Against Glucocorticoid Bone Loss

  2026-09-29

  This in vivo study identifies osteoclast overactivation as a therapeutically relevant component of glucocorticoid-induced osteonecrosis of the femoral head and shows that cycloastragenol reduces structural, vascular, molecular, and histologic injury in methylprednisolone-exposed rats. Its main practical value is the integration of micro-CT, angiography, histology, RT-qPCR, and Western blotting into a coherent preclinical evaluation framework.

• P2Y11 Antagonist NF 340: Assay Workflows

  2026-09-28

  NF 340 enables mechanism-focused studies of P2Y11 signaling in breast cancer migration, invasion, and myosin light-chain phosphorylation. This guide connects the reference study to practical compound handling, assay controls, dose-finding, and troubleshooting for oncology, GPCR, and immunology research.

• TSA as a Translational Probe for Epigenetic Biology

  2026-09-28

  Trichostatin A (TSA) is a useful HDAC-inhibition tool for testing how histone acetylation shapes cancer-cell state. This article connects its mechanism to rigorous validation, practical experiment design, and translational limits.

• LNP Charge and V-ATPase Shape Nucleic Acid Delivery

  2026-09-27

  A 2026 study proposes that lipid nanoparticle surface charge and target-cell V-ATPase activity jointly influence functional nucleic acid delivery, with different charge states associated with liver or lung delivery in vivo. The findings highlight target-cell biology as a variable in LNP performance, while leaving important questions about mechanisms, model dependence, and clinical transferability open.

• β-Elemene for 3T3-L1 Adipogenesis Research

  2026-09-26

  Use β-Elemene to probe adipocyte differentiation and insulin-resistance phenotypes in a 3T3-L1 workflow, with lipid staining, triglyceride measurement, and glucose consumption as complementary readouts. The reference study links these metabolic effects to AMPK pathway regulation, while practical dose-ranging and vehicle controls help separate biological activity from assay artifacts.

• UHRF1, Super-Enhancers, and Osteogenesis in Aging

  2026-09-25

  A multi-omics study links reduced UHRF1-associated DNA 5-methylcytosine to super-enhancer redistribution and impaired mesenchymal stem-cell osteogenesis in senile osteoporosis. Its findings place TGM2-regulated autophagic flux within this pathway and report that targeting the UHRF1–TGM2 axis can improve bone loss in a mouse model.

• LNP Surface Charge Meets Cellular V-ATPase Activity

  2026-09-25

  This study proposes that LNP delivery depends not only on particle surface charge but also on the V-ATPase activity of the target cell. Its in vitro and in vivo findings suggest that considering both sides of this interaction may help explain charge-associated delivery patterns, while highlighting the need to test cell state alongside nanoparticle design.

• Lapatinib Assays for EGFR and HER2 Research

  2026-09-24

  Connect Lapatinib’s nanomolar biochemical activity to receptor-defined cell assays, proliferation readouts, and metastasis-associated phenotypes. A recent breast cancer study also offers a useful, carefully qualified framework for testing Lapatinib combinations in HER2-negative cells without mistaking phenotype changes for proof of target engagement.

• Trichostatin A: From Chromatin to Ferroptosis

  2026-09-24

  HDAC3–NRF2–GPX4 findings in colorectal cancer create a testable direction for epigenetic research. Learn how Trichostatin A can help investigate broad HDAC effects—without confusing them with HDAC3-specific evidence.

• Cefiderocol Against Resistant European Enterobacterales

  2026-09-23

  A six-country European surveillance study found that cefiderocol retained in vitro activity against many Enterobacterales isolates resistant to meropenem and β-lactam/β-lactamase inhibitor combinations. Its comparative susceptibility results and genetic analysis support early, isolate-specific testing, while the findings remain laboratory evidence rather than proof of clinical outcomes.

• CTOP: μ-Opioid Receptor Antagonist Workflows

  2026-09-23

  CTOP provides a selective pharmacological switch for testing whether μ-opioid receptor activation drives cellular signaling, mechanical hypersensitivity, or opioid tolerance. This workflow connects receptor assays with route-matched mouse pain experiments while emphasizing controls, timing, sample handling, and interpretation.

• Epoxomicin and the Proteasome Logic of Viral Inflammation

  2026-09-22

  Viral immune evasion is often framed as a signaling problem, but the targeted destruction of RIPK3 shows why protein turnover deserves equal attention. This thought-leadership analysis explains how Epoxomicin can help translational researchers test proteasome dependence in virus-induced inflammation, design more rigorous protein degradation assays, and distinguish mechanistic evidence from therapeutic promise.

• How Cholesterol Hinders LNP Intracellular Trafficking

  2026-09-22

  A 2025 study developed a sensitive imaging platform to distinguish LNP uptake from productive intracellular trafficking of nucleic acid cargo. Its results show that increasing cholesterol can promote aggregation of LNP-containing peripheral early endosomes, restricting access to downstream endolysosomal compartments and reducing delivery efficiency.

• Protease Inhibitor Cocktail for ENaC Processing

  2026-09-21

  The Protease Inhibitor Cocktail helps preserve ENaC cleavage states during kidney protein extraction. This article connects EDTA-free protease control with the interpretation of salt- and ADH-dependent trafficking experiments, offering practical guidance for phosphorylation-compatible assays and protease inhibition in cell lysates.

8164 records 1/545 page Next 12345 下5页 Last page